Back to Results

A Double-blind Randomized Placebo-controlled Parallel Design Multicenter Phase IIIb Study of the Effect of Sodium Zirconium Cyclosilicate (SZC) on Serum Potassium and Serum Bicarbonate in Pateitns with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease (NEUTRALIZE)

Study category: Kidney Disease & Hypertension

Is this Study for You?

Let's Get Started!

Description

This is a 36 day trial with 18 in-person visits comparing the effect of Lokelma vs. placebo on serum potassium and bicarbonate levels.

Details
Age

Adult

Eligibility

-18 years or older -CKD stage 3-5 with GFR of 30-59 -Potassium level of 5.1-5.9 -Carbon dioxide level of 16-20

Type of Study

Treatment

Location

Renal Research Center

Principal Investigator
Jessica Kendrick,  MD

Jessica Kendrick, MD

Study ID

Protocol Number: 21-2470

More information available at ClinicalTrials.gov: NCT04727528

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers